
Aarti Pharmalabs Ltd is Rated Sell by MarketsMOJO
2026-05-19 10:11:09Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
09-Aug-2026 | Source : BSENewspaper Publication on Financial Results
Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30 2026
07-Aug-2026 | Source : BSEApproval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter Ended June 30 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
07-Aug-2026 | Source : BSEDisclosure as enclosed
Corporate Actions
No Upcoming Board Meetings
Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26
No Splits history available
No Bonus history available
No Rights history available